drugset / Trial / NCT07423559

Relapse Among Diabetic Ketoacidosis Patients Maintained Basal Bolus Insulin Administration in Combination With Continuous Intravenous Insulin Infusion VS Non Maintaining Basal Insulin Patients

NCT07423559 ↗

Completed 100 enrolled Tanta University
RandomizedParallel-groupDouble-blindPrevention

Summary

This study aimed to assess intensive care unit stay and relapse among patients of Diabetic ketoacidosis (type 1 diabetes mellitus) maintained basal bolus insulin and patients non maintaining along with intervenors insulin infusion.

Timeline

Start
2023-11-30
Primary completion
2024-12-30
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic — Intravenous

Indications